Attar Eyal C.

Track

Insider profile

Attar Eyal C.'s trades of Vor Biopharma Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-18 2025-02-13
PlS Planned sale
45,912 -41.8%
324.02
US$2,646,526 		45,912 -41.8% 324.02 US$2,646,526
2025-02-13 2025-02-13
PrS Proposed sale
64,226
247.19
US$3,466,613 		64,226 247.19 US$3,466,613
2025-02-12 2025-02-10
PlS Planned sale
74,309 -38.4%
280.21
US$3,208,805 		74,309 -38.4% 280.21 US$3,208,805
2025-02-10 2025-02-10
PrS Proposed sale
2,554
1.41
US$3,601 		2,554 1.41 US$3,601
2024-12-31 2024-12-27
PlS Planned sale
10,334 -11.3%
1.25
US$12,918 		10,334 -11.3% 1.25 US$12,918
2024-12-27 2024-12-27
PrS Proposed sale
10,334
0.84
US$8,660 		10,334 0.84 US$8,660
2024-06-04 2024-06-03
PlS Planned sale
14,645 -13.2%
1.39
US$20,357 		14,645 -13.2% 1.39 US$20,357
2024-06-03 2024-06-03
PrS Proposed sale
14,645
1.35
US$19,771 		14,645 1.35 US$19,771
2022-03-01 2022-02-28
PlS Planned sale
36,000 -43.4%
1.73
US$62,280 		36,000 -43.4% 1.73 US$62,280
2019-10-07 2019-10-07
B Purchase
200 +inf%
15.00
US$3,000 		200 +inf% 15.00 US$3,000
2019-10-07 2019-10-07
B Purchase
200 +inf%
15.00
US$3,000 		200 +inf% 15.00 US$3,000